Journal article

Depressive symptoms in first episode schizophrenia spectrum disorder

SM Cotton, M Lambert, BG Schimmelmann, A Mackinnon, JFM Gleeson, M Berk, L Hides, A Chanen, PD McGorry, P Conus

Schizophrenia Research | Published : 2012

Abstract

Background: Depressive symptoms in 'non-affective' first episode schizophrenia spectrum disorders (FES) are common, but poorly understood, resulting in a range of conceptual and clinical management issues. This study had three aims: (i) to determine the prevalence of moderate to severe depressive symptoms (defined as a Clinical Global Impressions Scale-Bipolar Disorder (CGI-BP depression) score > 3) in a large representative sample of FES patients; (ii) to compare the clinical and functional characteristics of FES patients with and without these depressive symptoms at service entry; and (iii) to compare the characteristics of FES patients with and without persistent depressive symptoms. Meth..

View full abstract

Grants

Funding Acknowledgements

The First Episode Outcome Study (FEPOS) was supported by a grant to Prof. Martin Lambert from Eli Lilly Company Australia, and a grant to Prof. Philippe Corms from the Leenaards Foundation, Switzerland. Eli Lilly Australia funded the assessment of files on a subgroup of this cohort treated with olanzapine and risperidone. Associate Prof. Sue Cotton is supported by the Ronald Phillip Griffith Fellowship, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne.